These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


241 related items for PubMed ID: 34363547

  • 1. Serum sodium level associated with coronary artery lesions in patients with Kawasaki disease.
    Masuda H, Ae R, Koshimizu TA, Matsumura M, Kosami K, Hayashida K, Makino N, Matsubara Y, Sasahara T, Nakamura Y.
    Clin Rheumatol; 2022 Jan; 41(1):137-145. PubMed ID: 34363547
    [Abstract] [Full Text] [Related]

  • 2. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J, Liu P, Hu W, Xu Y, Deng J.
    Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
    [Abstract] [Full Text] [Related]

  • 3. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 4. Kawasaki Disease With Coronary Artery Lesions Detected at Initial Echocardiography.
    Ae R, Maddox RA, Abrams JY, Schonberger LB, Nakamura Y, Kuwabara M, Makino N, Kosami K, Matsubara Y, Matsubara D, Sasahara T, Belay ED.
    J Am Heart Assoc; 2021 Apr 06; 10(7):e019853. PubMed ID: 33787310
    [Abstract] [Full Text] [Related]

  • 5. Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki Disease: a retrospective cohort study.
    Shuai S, Zhang H, Zhang R, Tang M, Luo E, Yang Y, Gao Y, Yue S, Liang H, Cai J.
    J Pediatr (Rio J); 2023 Apr 06; 99(4):406-412. PubMed ID: 36977496
    [Abstract] [Full Text] [Related]

  • 6. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
    Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
    J Int Med Res; 2024 May 06; 52(5):3000605241252115. PubMed ID: 38713460
    [Abstract] [Full Text] [Related]

  • 7. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.
    Wu Y, Wang S, Zhou Y, Yang Y, Li S, Yin W, Ding Y.
    PLoS One; 2023 May 06; 18(10):e0292653. PubMed ID: 37824465
    [Abstract] [Full Text] [Related]

  • 8. Predictive Value of Serum Lipid for Intravenous Immunoglobulin Resistance and Coronary Artery Lesion in Kawasaki Disease.
    Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C.
    J Clin Endocrinol Metab; 2021 Sep 27; 106(10):e4210-e4220. PubMed ID: 33837779
    [Abstract] [Full Text] [Related]

  • 9. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
    Pediatr Infect Dis J; 2018 Oct 27; 37(10):976-980. PubMed ID: 29461447
    [Abstract] [Full Text] [Related]

  • 10. Red Blood Cell Distribution Width as a Predictive Marker for Coronary Artery Lesions in Patients with Kawasaki Disease.
    Ming L, Cao HL, Li Q, Yu G.
    Pediatr Cardiol; 2021 Oct 27; 42(7):1496-1503. PubMed ID: 34036412
    [Abstract] [Full Text] [Related]

  • 11. Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period.
    Giannouli G, Tzoumaka-Bakoula C, Kopsidas I, Papadogeorgou P, Chrousos GP, Michos A.
    Pediatr Cardiol; 2013 Aug 27; 34(6):1476-81. PubMed ID: 23463134
    [Abstract] [Full Text] [Related]

  • 12. Association between adropin and coronary artery lesions in children with Kawasaki disease.
    Yang M, Pei Q, Zhang J, Weng H, Jing F, Yi Q.
    Eur J Pediatr; 2021 Jul 27; 180(7):2253-2259. PubMed ID: 33712900
    [Abstract] [Full Text] [Related]

  • 13. High Serum Total IgE at Admission Is Associated with Coronary Artery Lesions in Children with Kawasaki Disease.
    Wang Z, Liu X, Duan Z, Peng Y.
    J Trop Pediatr; 2022 Jan 07; 68(1):. PubMed ID: 35043965
    [Abstract] [Full Text] [Related]

  • 14. Single-Cell Transcriptome Reveals Potential Mechanisms for Coronary Artery Lesions in Kawasaki Disease.
    Chen Y, Yang M, Zhang M, Wang H, Zheng Y, Sun R, Li X.
    Arterioscler Thromb Vasc Biol; 2024 Apr 07; 44(4):866-882. PubMed ID: 38357816
    [Abstract] [Full Text] [Related]

  • 15. Outcomes in Kawasaki disease patients with coronary artery abnormalities at admission.
    Ae R, Abrams JY, Maddox RA, Schonberger LB, Nakamura Y, Kuwabara M, Makino N, Matsubara Y, Matsubara D, Kosami K, Sasahara T, Belay ED.
    Am Heart J; 2020 Jul 07; 225():120-128. PubMed ID: 32497905
    [Abstract] [Full Text] [Related]

  • 16. AST-to-ALT ratio and coronary artery lesions among patients with Kawasaki disease.
    Cao L, Tang YJ, Gang M, Ma J, Qian WG, Xu QQ, Lv HT.
    World J Pediatr; 2021 Dec 07; 17(6):659-668. PubMed ID: 34792780
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.
    Weng KP, Hsieh KS, Huang SH, Ou SF, Lai TJ, Tang CW, Lin CC, Ho TY, Liou HH, Ger LP.
    J Chin Med Assoc; 2013 Aug 07; 76(8):438-45. PubMed ID: 23769880
    [Abstract] [Full Text] [Related]

  • 18. The expression and significance of serum caveolin-1 in patients with Kawasaki disease.
    Zhu F, Huang J, Wang X, Li P, Yan Y, Zheng Y, He Y, Wu T, Ren Y, Wu R.
    Chin J Physiol; 2020 Aug 07; 63(2):90-94. PubMed ID: 32341235
    [Abstract] [Full Text] [Related]

  • 19. Development of a prediction model for progression of coronary artery lesions in Kawasaki disease.
    Xu D, Chen YS, Feng CH, Cao AM, Li XH.
    Pediatr Res; 2024 Mar 07; 95(4):1041-1050. PubMed ID: 38040988
    [Abstract] [Full Text] [Related]

  • 20. Plasma proteomic profiling reveals that SERPINE1 is a potential biomarker associated with coronary artery lesions in Kawasaki disease.
    Wang N, Gao Y, Wang Y, Dai Y, Tang Y, Huang J, Sun L, Qian G, Ma J, Li X, Liu Y, Yang D, Huang X, Wang W, Li W, Zhuo W, Lv H, Liu Z.
    Int Immunopharmacol; 2024 Sep 30; 139():112698. PubMed ID: 39029232
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.